NewsIn memory
What Walter Payton's Story Can Help Us Understand About Bile Duct Cancer
The Hall of Fame running back died of bile duct cancer (cholangiocarcinoma) in 1999. Here is what that diagnosis means, explained calmly and simply.
A plain-language summary based on public reporting and trusted sources, linked below.
Please note: this page is educational only — it is not medical advice, and it does not speculate about anyone’s health beyond reliable public reporting. For questions about your own health, talk with your healthcare team.
What was reported at the time
In February 1999, Walter Payton announced he had a rare liver disease and would need a transplant. The disease was primary sclerosing cholangitis, in which the bile ducts become blocked by inflammation and scarring.
During that year, doctors found something else. The Associated Press reported in November 1999 that Payton had not only primary sclerosing cholangitis but bile duct cancer as well, and that the cancer had spread outside his liver, which made a transplant impossible.
He died on November 1, 1999, at the age of 45. ESPN's obituary records that the cancer had been discovered earlier that year, during treatment for the liver disease.
Those are the reported facts. The rest of this page is about the disease, because that is the part that can be useful to someone reading now.
Where these tumors start
Bile is a fluid the liver makes to help digest fat. It travels through a branching set of tubes called bile ducts, down to the small intestine.
Cancer can start anywhere along that plumbing. NCI divides it in two. Intrahepatic bile duct cancer forms in the ducts inside the liver, and NCI notes that only a small number of these cancers are intrahepatic. Extrahepatic bile duct cancer forms in the ducts outside the liver. The medical name for either is cholangiocarcinoma.
Location matters more than it might sound. It decides which operation is possible, and whether one is possible at all.
The link Payton's case shows
Primary sclerosing cholangitis, usually shortened to PSC, is on NCI's list of risk factors for bile duct cancer. So are chronic ulcerative colitis, cysts in the bile ducts, and infection with a Chinese liver fluke parasite.
PSC and ulcerative colitis often occur in the same person. Anyone living with PSC is normally under long-term specialist care partly for this reason. NCI is careful to add that most people with a risk factor never develop the disease, and some people who develop it have no known risk factor.
The signs
NCI lists these signs of bile duct cancer:
- jaundice, meaning yellowing of the skin or the whites of the eyes.
- dark urine.
- clay-colored stool.
- pain in the abdomen.
- fever.
- itchy skin.
- nausea and vomiting.
- weight loss for an unknown reason.
Jaundice is the one that gets people seen. It happens when a blocked duct sends bile pigment into the blood instead of the gut. That is also why the stool loses its color and the urine darkens. Itchy skin without a rash, especially with any yellow tint, is worth an urgent appointment.
How it is worked up
NCI states that there are no routine screening tests for bile duct cancer before signs and symptoms appear. There is no equivalent of a mammogram here.
Diagnosis relies on imaging of the ducts and the area around them, done alongside staging, since both questions are answered by the same scans. Blood work includes CA 19-9, a tumor marker whose level NCI lists among the factors affecting prognosis and treatment options. Our page on cancer diagnosis covers what the waiting period between tests involves.
The central question through all of it is whether surgery can remove the cancer completely.
What treatment looks like
When the cancer has not spread and sits where an operation is safe, surgeons remove the tumor and a margin of tissue around it. For intrahepatic disease that can mean a partial hepatectomy, the removal of part of the liver. Chemotherapy, with or without radiation, may follow.
When the cancer cannot be removed, much of the work is relieving the blockage. A stent, which is a small tube that holds a duct open, or a drain placed through the skin, can clear jaundice and the itching that comes with it. NCI lists these as palliative measures, meaning they treat symptoms rather than the cancer.
The numbers, plainly
SEER groups liver and intrahepatic bile duct cancer together. Five-year relative survival for that combined group is 21.9 percent for people diagnosed from 2016 to 2022. By extent, it is 37.4 percent for local disease, 13.4 percent for regional disease, and 3.6 percent for distant disease. About 45 percent are found while still local.
These are hard numbers, and they are group averages across a mixed category. They do not describe an individual, and they say nothing about anyone reading this. Our overview of liver cancer explains how the two diseases in that SEER category differ.
When to get checked
Go the same week if you notice yellowing of the eyes or skin, pale stools with dark urine, or unexplained itching that does not settle. Go sooner if these come with abdominal pain, fever, or weight loss you did not intend.
If you have been diagnosed with primary sclerosing cholangitis or ulcerative colitis, ask your specialist directly how your bile ducts are monitored and what would trigger further imaging.
What this story cannot tell you
- Reporting from 1999 describes what was known then. Imaging, surgery, and drug options have all changed since.
- Bile duct cancer is uncommon. Most jaundice and most itching have other causes.
- Having primary sclerosing cholangitis does not mean cancer will follow. It means monitoring is warranted.
- Nothing on this page is a comment on anyone's individual medical care, then or now.
Sources
- ESPN SportsCentury: Payton, NFL's career rushing leader, dies at 45
- Associated Press via ESPN, November 1999
- NCI: What Is Bile Duct Cancer (Cholangiocarcinoma)?
- NCI: Bile Duct Cancer Causes and Risk Factors
- NCI: Bile Duct Cancer Diagnosis
- NCI: Bile Duct Cancer Treatment (PDQ) — Patient Version
- SEER Cancer Stat Facts: Liver and Intrahepatic Bile Duct Cancer
How this page was made
An AI-assisted editorial system helped prepare this page. This article has not been reviewed by a healthcare professional unless a named reviewer is specifically shown. Cancer Explained is published by the National Cancer Information Foundation as a nonprofit-oriented public-interest education project. It is not a diagnostic service, does not recommend treatments, and is not for emergencies.
Found an error, a broken source link, outdated information, or wording that feels insensitive? Report it here — we log and act on material corrections.
Know someone who needs this?
Plenty of people are looking for something like this and do not know where to start. If this would help a friend or someone you love, send it on — we have written an opening line so you do not have to stare at an empty message. You can change every word of it.
Your message is written and sent in your own email or messaging app — we never see who you send it to, and nothing is added to any list.
Put the story in context
Prevention, possible warning signs, screening, and diagnosis
This story relates to Bile duct cancer (cholangiocarcinoma). The information below is general: it does not reveal anything else about a public person’s health, and not every point applies to every cancer. Personal advice depends on age, symptoms, family history, exposures, and medical history.
Prevention and risk reduction
Not every cancer can be prevented. Avoiding tobacco, protecting skin from ultraviolet radiation, limiting alcohol, staying active, and receiving recommended HPV or hepatitis B vaccination can lower the risk of certain cancers. A risk factor is not a prediction or a cause in one individual.
Symptoms and possible early signs
Possible signs vary and are often caused by conditions other than cancer. Changes worth discussing include a new lump, unexplained bleeding or weight loss, a persistent cough, lasting bowel or bladder changes, a changing skin spot, or symptoms that persist or worsen. Some early cancers cause no symptoms.
Screening and early detection
Screening looks for certain cancers before symptoms begin. Recommended tests exist only for some cancers and depend on age and risk. Screening can have benefits and harms; it is not the same as evaluating a new symptom, and there is no single routine scan or blood test that reliably screens for every cancer.
How cancer is diagnosed
Diagnosis may involve a history and exam, imaging, laboratory tests, and often a biopsy. Pathology can identify the cancer type and may test biomarkers that guide treatment. Symptoms, screening results, tumor markers, or online stories alone cannot confirm cancer.
Learn about this story’s cancer topic
A public story may encourage questions, but it should not be used to estimate your risk or choose testing. Contact a healthcare professional about a persistent or concerning change. Seek urgent care for severe or rapidly worsening symptoms.